Cipta Sarana Medika Tbk. vs Suparma Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Suparma Tbk. trades at Rp168 (market cap 697.05B, 339.9K 24h volume). The key difference: Suparma Tbk. is far larger — about 4.4× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 339.9K). Which is the better fit depends on your goals.
| DKHH | SPMA | |
|---|---|---|
Market Cap | 158.12B | 697.05B |
Volume | 8.21M | 339.9K |
Lot | 82.15K | 3.4K |
Turnover | 515.2M | 57.35M |
Average Price | 62.72 | 168.71 |
Value | 515.2M | 57.35M |
Indicative Equilibrium Price | 63 | 168 |
Indicative Equilibrium Volume | 1.33K | 2 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Read more on SPMA →